Cargando…

Advances in the treatment of polyarticular juvenile idiopathic arthritis

PURPOSE OF REVIEW: To review recent advances in the management strategies of polyarticular course juvenile idiopathic arthritis (JIA) and identify unanswered questions and avenues for further research. RECENT FINDINGS: There is evidence for an early, aggressive, treat-to-target approach for polyarti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webb, Kate, Wedderburn, Lucy R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2015
Materias:	PEDIATRIC AND HERITABLE DISORDERS: Edited by Polly J. Ferguson
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521899/ https://www.ncbi.nlm.nih.gov/pubmed/26147756 http://dx.doi.org/10.1097/BOR.0000000000000206

Ejemplares similares

Brief Report: The Genetic Profile of Rheumatoid Factor–Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis
por: Hinks, Anne, et al.
Publicado: (2018)

Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate
por: Lovell, Daniel J, et al.
Publicado: (2020)

Model‐Based Selection and Recommendation for Subcutaneous Abatacept Dose in Patients With Polyarticular Juvenile Idiopathic Arthritis
por: Gandhi, Yash, et al.
Publicado: (2021)

Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results
por: Brunner, Hermine I., et al.
Publicado: (2020)

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
por: Bakry, Reima, et al.
Publicado: (2022)

Polyarticular juvenile idiopathic arthritis – epidemiology and management approaches
por: Oberle, Edward J, et al.
Publicado: (2014)

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis
por: Wu, Qiong, et al.
Publicado: (2016)

Current Developments in the Use of Biomarkers for Juvenile Idiopathic Arthritis
por: Duurland, Chantal L., et al.
Publicado: (2014)

Whole Blood Gene Expression Profiling Predicts Therapeutic Response at Six Months in Patients With Polyarticular Juvenile Idiopathic Arthritis
por: Jiang, Kaiyu, et al.
Publicado: (2014)

Peripheral Blood Lymphocyte Analysis in Oligo- and Polyarticular Juvenile Idiopathic Arthritis Patients Receiving Methotrexate or Adalimumab Therapy: A Cross-Sectional Study
por: Nagy, Arnold, et al.
Publicado: (2020)

Radiological cervical spine involvement in polyarticular idiopathic juvenile arthritis
por: Wipff, J, et al.
Publicado: (2011)

Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
por: Kimura, Yukiko, et al.
Publicado: (2021)

Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: Results From a Phase III Open‐Label Study
por: Brunner, Hermine I., et al.
Publicado: (2018)

Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations
por: McIntosh, Sydney Moore, et al.
Publicado: (2023)

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial
por: Brunner, Hermine I., et al.
Publicado: (2021)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Safety and Effectiveness of Tofacitinib in Treating Polyarticular Course Juvenile Idiopathic Arthritis
por: Jones, Nicholas T, et al.
Publicado: (2023)

Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis
por: Shoop‐Worrall, Stephanie J. W., et al.
Publicado: (2020)

Slow speed resistance exercise training in children with polyarticular juvenile idiopathic arthritis
por: Sule, Sangeeta D, et al.
Publicado: (2019)

Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis
por: Marangoni, Roberta Gonçalves, et al.
Publicado: (2011)

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
por: Ruperto, Nicolino, et al.
Publicado: (2021)

Study of the shared gene signatures of polyarticular juvenile idiopathic arthritis and autoimmune uveitis
por: Zheng, Jie, et al.
Publicado: (2023)

High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
por: Mor‐Vaknin, Nirit, et al.
Publicado: (2018)

Correlation of Low CD73 Expression on Synovial Lymphocytes With Reduced Adenosine Generation and Higher Disease Severity in Juvenile Idiopathic Arthritis
por: Botta Gordon‐Smith, Sophie, et al.
Publicado: (2015)

Isolated Facet Joint Arthritis in Juvenile Idiopathic Arthritis
por: Martone, Giulia, et al.
Publicado: (2021)

PAIN PERCEPTION AND PAIN COPING MECHANISMS IN CHILDREN AND ADOLESCENTS WITH JUVENILE FIBROMYALGIA AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
por: Fraga, Melissa Mariti, et al.
Publicado: (2018)

Innate Lymphoid Cells and T Cells Contribute to the Interleukin‐17A Signature Detected in the Synovial Fluid of Patients With Juvenile Idiopathic Arthritis
por: Rosser, Elizabeth C., et al.
Publicado: (2019)

Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab
por: Minden, Kirsten, et al.
Publicado: (2014)

Indirect comparison of etanercept and abatacept efficacy and safety in patients with polyarticular juvenile idiopathic arthritis
por: Loskutova (Konopelko), OU, et al.
Publicado: (2014)

JAK inhibitors in systemic juvenile idiopathic arthritis
por: He, Tingyan, et al.
Publicado: (2023)

Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review
por: Chaplin, Hema, et al.
Publicado: (2021)

Childhood-Onset COPA Syndrome Recognized Retrospectively in the Context of Polyarticular Juvenile Idiopathic Arthritis and Rheumatoid Arthritis
por: Nikolic, Roko P. A., et al.
Publicado: (2023)

PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study
por: Hissink Muller, PC, et al.
Publicado: (2013)

Polyarticular juvenile idiopathic arthritis (pJIA): clinical and serologic predictors of inactive disease (ID)
por: Meiorin, Silvia
Publicado: (2014)

A Novel Method for Pathway Identification Based on Attractor and Crosstalk in Polyarticular Juvenile Idiopathic Arthritis
por: Wang, Yuanji, et al.
Publicado: (2016)

Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis
por: Ruperto, Nicolino, et al.
Publicado: (2021)

Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis
por: Soulsby, William Daniel, et al.
Publicado: (2022)

α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
por: Zeller, Ludwig, et al.
Publicado: (2022)

Identification of key biomarkers in RF-negative polyarticular and oligoarticular juvenile idiopathic arthritis by bioinformatic analysis
por: Liu, Yun, et al.
Publicado: (2023)

Wilson’s Disease Masquerading as Juvenile Idiopathic Arthritis in an Adolescent
por: Goyal, Rajeev, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o6pc0v55s6jinclf5n6ej14r2u